Brokerages Set Xenon Pharmaceuticals Inc. (NASDAQ:XENE) PT at $56.00
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) have been assigned an average recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The […]
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) have been assigned an average recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The […]
